biotechtranslated.com
Vivus’ new obesity drug: Will it get scooped by generics before it even hits the market?
This past Wednesday, the FDA approved Belviq, the recently renamed obesity drug from Arena. It wasn’t a huge surprise since the FDA review panel gave a strong 18-4 vote of support for its ap…